Tutorials
ASX:CSL (Australia)  
CSL Ltd logo

CSL Ltd

A$ 296.75 (+0.73%) Aug 5
On watch
P/E:
42.45
P/B:
7.24
Market Cap:
A$ 142.95B ($ 99.02B)
Enterprise V:
A$ 141.84B ($ 98.25B)
Volume:
636.13K
Avg Vol (2M):
885.48K
Also Trade In:
Volume:
636.13K
Market Cap A$:
142.95B
Market Cap $:
99.02B
PE Ratio:
42.45
Avg Vol (2-Month):
885.48K
Enterprise Value A$:
141.84B
Enterprise Value $:
98.25B
PB Ratio:
7.24
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

CSL Ltd
NAICS : 325411
45 Poplar Road, Parkville, Melbourne, VIC, AUS, 3052
Description
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

Financials (Next Earnings Date:2022-08-17)

ASX:CSL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 14,226.618
EPS (TTM) (A$) 6.99
Beta 0.36
Volatility % 18.61
14-Day RSI 61.57
14-Day ATR (A$) 5.291404
20-Day SMA (A$) 293.3935
12-1 Month Momentum % -5.05
52-Week Range (A$) 240.1 - 319.78
Shares Outstanding (Mil) 481.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CSL Ltd Filings

Document Form Filing Date
No Filing Data